Treatment of recurrent myopic macular hole using membrane of plasma rich in growth factors
| Autor: | Álvaro Fernández-Vega Sanz, Ronald M Sanchez-Avila, Alvaro Fernández-Vega González, Jesus Merayo-Lloves |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Pars plana
medicine.medical_specialty Visual acuity genetic structures business.industry Internal limiting membrane medicine.medical_treatment Vitrectomy General Medicine 030204 cardiovascular system & hematology medicine.disease eye diseases 03 medical and health sciences Retinal surgery 0302 clinical medicine medicine.anatomical_structure Ophthalmology 030221 ophthalmology & optometry medicine sense organs medicine.symptom business Macular hole |
| Zdroj: | International Medical Case Reports Journal. 12:229-233 |
| ISSN: | 1179-142X |
| DOI: | 10.2147/imcrj.s170329 |
| Popis: | Purpose To describe the case of a patient with a recurrent large myopic macular hole (MH), who was successfully treated with a plasma rich in growth factors (PRGF) membrane. Case Report A 71-year-old patient presented a myopic MH in his right eye. One month later, pars plana vitrectomy with internal limiting membrane (ILM) peeling was performed, achieving closure of the MH. Three months later a recurrence was observed (700 µm) without visual acuity (VA) improvement. A new surgery was carried out placing an autologous PRGF-membrane into the MH, and performing a fluid-gas exchange at the end of the surgery. After two months of follow-up, the MH was completely closed, obtaining the anatomic recovery of the foveal depression, and improving the VA to 0.1. No adverse reactions were associated with the use of PRGF and there were no new recurrences of the MH in a follow-up period of six months. Conclusion The use of PRGF-membrane can be used as adjunctive therapy in the surgical repair of recurrent large myopic MHs, thus improving anatomic and visual outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|